Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV). In the weeks since, a chaotic tug-of-war between physicians, health funds, patient groups and the cannabis industry has thrown the framework into further disarray. Fissures have now opened between the country’s statutory-insurance physicians a…